Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial (vol 4, e002015, 2015)

被引：1
|
作者：
Rao, M. P.
机构：
来源：
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2021年 / 10卷 / 04期
关键词：
D O I：
10.1161/JAHA.119.014653
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
    Rao, Meena P.
    Halvorsen, Sigrun
    Wojdyla, Daniel
    Thomas, Laine
    Alexander, John H.
    Hylek, Elaine M.
    Hanna, Michael
    Cecilia Bahit, M.
    Lopes, Renato D.
    De Caterina, Raffaele
    Erol, Cetin
    Goto, Shinya
    Lanas, Fernando
    Lewis, Basil S.
    Husted, Steen
    Gersh, Bernard J.
    Wallentin, Lars
    Granger, Christopher B.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2015, 4 (12):
  • [2] The 'obesity paradox' in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial
    Sandhu, Roopinder K.
    Ezekowitz, Justin
    Andersson, Ulrika
    Alexander, John H.
    Granger, Christopher B.
    Halvorsen, Sigrun
    Hanna, Michael
    Hijazi, Ziad
    Jansky, Petr
    Lopes, Renato D.
    Wallentin, Lars
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 (38) : 2869 - 2878
  • [3] Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
    Westenbrink, B. Daan
    Alings, Marco
    Granger, Christopher B.
    Alexander, John H.
    Lopes, Renato D.
    Hylek, Elaine M.
    Thomas, Laine
    Wojdyla, Daniel M.
    Hanna, Michael
    Keltai, Matyas
    Steg, P. Gabriel
    De Caterina, Raffaele
    Wallentin, Lars
    van Gilst, Wick H.
    [J]. AMERICAN HEART JOURNAL, 2017, 185 : 140 - 149
  • [4] Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale
    Lopes, Renato D.
    Alexander, John H.
    Al-Khatib, Sana M.
    Ansell, Jack
    Diaz, Raphael
    Easton, J. Donald
    Gersh, Bernard J.
    Granger, Christopher B.
    Hanna, Michael
    Horowitz, John
    Hylek, Elaine M.
    McMurray, John J. V.
    Verheugt, Freek W. A.
    Wallentin, Lars
    [J]. AMERICAN HEART JOURNAL, 2010, 159 (03) : 331 - 339
  • [5] Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
    Garcia, David A.
    Fisher, Deborah A.
    Mulder, Hillary
    Wruck, Lisa
    De Caterina, Raffele
    Halvorsen, Sigrun
    Granger, Christopher B.
    Held, Claes
    Wallentin, Lars
    Alexander, John H.
    Lopes, Renato D.
    [J]. AMERICAN HEART JOURNAL, 2020, 221 : 1 - 8
  • [6] Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
    Avezum, Alvaro
    Lopes, Renato D.
    Schulte, Phillip J.
    Lanas, Fernando
    Gersh, Bernard J.
    Hanna, Michael
    Pais, Prem
    Erol, Cetin
    Diaz, Rafael
    Cecilia Bahit, M.
    Bartunek, Jozef
    De Caterina, Raffaele
    Goto, Shinya
    Ruzyllo, Witold
    Zhu, Jun
    Granger, Christopher B.
    Alexander, John H.
    [J]. CIRCULATION, 2015, 132 (08) : 624 - 632
  • [7] BODY MASS INDEX AND OUTCOMES WITH APIXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ARISTOTLE (APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION) TRIAL
    Sandhu, Roopinder K.
    Ezekowitz, Justin
    Andersson, Ulrika
    Alexander, John
    Granger, Christopher
    Halvorsen, Sigrun
    Hanna, Michael
    Hijazi, Ziad
    Jansky, Petr
    Lopes, Renato
    Wallentin, Lars
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A284 - A284
  • [8] Efficacy and Safety of Apixaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation from East Asia: A Subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
    Goto, Shinya
    Zhu, Jun
    Liu, Lisheng
    Oh, Byung-Hee
    Wojdyla, Daniel M.
    Aylward, Philip
    Bahit, M. Cecilia
    Gersh, Bernard J.
    Hanna, Michael
    Horowitz, John
    Lopes, Renato D.
    Wallentin, Lars
    Xavier, Denis
    Alexander, John H.
    [J]. AMERICAN HEART JOURNAL, 2014, 168 (03) : 303 - 309
  • [9] Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial
    Pol, Tymon
    Held, Claes
    Westerbergh, Johan
    Lindback, Johan
    Alexander, John H.
    Alings, Marco
    Erol, Cetin
    Goto, Shinya
    Halvorsen, Sigrun
    Huber, Kurt
    Hanna, Michael
    Lopes, Renato D.
    Ruzyllo, Witold
    Granger, Christopher B.
    Hijazi, Ziad
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (03):
  • [10] High-Sensitivity Troponin I for Risk Assessment in Patients With Atrial Fibrillation Insights From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
    Hijazi, Ziad
    Siegbahn, Agneta
    Andersson, Ulrika
    Granger, Christopher B.
    Alexander, John H.
    Atar, Dan
    Gersh, Bernard J.
    Mohan, Puneet
    Harjola, Veli-Pekka
    Horowitz, John
    Husted, Steen
    Hylek, Elaine M.
    Lopes, Renato D.
    McMurray, John J. V.
    Wallentin, Lars
    [J]. CIRCULATION, 2014, 129 (06) : 625 - 634
12345